4//SEC Filing
Posner Christopher 4
Accession 0001209191-22-023237
CIK 0001346830other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:48 PM ET
Size
5.2 KB
Accession
0001209191-22-023237
Insider Transaction Report
Form 4
Posner Christopher
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2022-04-04$12.67/sh−2,006$25,416→ 201,031 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on May 28, 2021 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on November 3, 2021, and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001748265
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:48 PM ET
- Size
- 5.2 KB